Raras
Buscar doenças, sintomas, genes...
Holoprosencefalia semilobar
ORPHA:220386CID-10 · Q04.2CID-11 · LA05.2DOENÇA RARA

A holoprosencefalia (HPE) é uma má formação cerebral complexa resultante da clivagem incompleta do prosencéfalo, entre os dias 18 e 28 de gestação. Durante o desenvolvimento normal, forma-se o lóbulo frontal e o rosto começa a desenvolver-se a partir da quarta até a oitava semana da gravidez, na HPE o lóbulo frontal do cérebro do embrião não se divide para formar os hemisférios cerebrais bilaterais, causando defeitos no desenvolvimento da face, na estrutura e no funcionamento do cérebro de gravidade variável.

Mantido por Agente Raras·Colaborar como especialista →

Introdução

O que você precisa saber de cara

📋

A holoprosencefalia semilobar é uma das formas clássicas de holoprosencefalia (HPE, ver este termo) em que os lobos frontais e parietais esquerdo e direito estão fundidos e a fissura inter-hemisférica está presente apenas posteriormente.

Publicações científicas
110 artigos
Último publicado: 2025 Dec

Escala de raridade

CLASSIFICAÇÃO ORPHANET · BRASIL 2024
1-9 / 100 000
Ultra-rara
<1/50k
Muito rara
1/20k
Rara
1/10k
Pouco freq.
1/5k
Incomum
1/2k
Prevalência
0.0
Europe
Início
Infancy
+ neonatal
🏥
SUS: Cobertura mínimaScore: 15%
CID-10: Q04.2
🇧🇷Dados SUS / DATASUS
PROCEDIMENTOS SIGTAP (5)
0202010503
Cariótipo — bandas G, Q ou Rgenetic_test
0202010600
Pesquisa de microdeleções/microduplicações por FISHlab_test
0202010694
Sequenciamento completo do exoma (WES)rehabilitation
0202010260
Dosagem de alfa-fetoproteína
0301070040
Atendimento em reabilitação — doenças raras
Você se identifica com essa condição?
O Raras está aqui pra te apoiar — com ou sem diagnóstico

Encontrou um erro ou informação desatualizada? Sugira uma correção →

Entender a doença

Do básico ao detalhe, leia no seu ritmo

Preparando trilha educativa...

Sinais e sintomas

O que aparece no corpo e com que frequência cada sintoma acontece

Partes do corpo afetadas

🧠
Neurológico
13 sintomas
📏
Crescimento
9 sintomas
🫃
Digestivo
5 sintomas
🦴
Ossos e articulações
5 sintomas
😀
Face
5 sintomas
🫁
Pulmão
4 sintomas

+ 23 sintomas em outras categorias

Características mais comuns

90%prev.
Baixa estatura
Muito frequente (99-80%)
90%prev.
Dificuldades alimentares
Muito frequente (99-80%)
90%prev.
Anormalidade do olho
Muito frequente (99-80%)
90%prev.
Hipotelorismo
Muito frequente (99-80%)
90%prev.
Atraso de crescimento
Muito frequente (99-80%)
90%prev.
Déficit de crescimento
Muito frequente (99-80%)
72sintomas
Muito frequente (7)
Frequente (41)
Ocasional (24)

Os sintomas variam de pessoa para pessoa. Abaixo estão as 72 características clínicas mais associadas, ordenadas por frequência.

Baixa estaturaShort stature
Muito frequente (99-80%)90%
Dificuldades alimentaresFeeding difficulties
Muito frequente (99-80%)90%
Anormalidade do olhoAbnormality of the eye
Muito frequente (99-80%)90%
HipotelorismoHypotelorism
Muito frequente (99-80%)90%
Atraso de crescimentoGrowth delay
Muito frequente (99-80%)90%

Linha do tempo da pesquisa

Publicações por ano — veja quando o interesse científico cresceu
Anos de pesquisa1desde 2025
Total histórico110PubMed
Últimos 10 anos31publicações
Pico20236 papers
Linha do tempo
2025Hoje · 2026📈 2023Ano de pico
Publicações por ano (últimos 10 anos)

Encontrou um erro ou informação desatualizada? Sugira uma correção →

Genética e causas

O que está alterado no DNA e como passa nas famílias

Genes associados

18 genes identificados com associação a esta condição. Padrão de herança: Multigenic/multifactorial, Not applicable.

ZIC2Zinc finger protein ZIC 2Disease-causing germline mutation(s) inAltamente restrito
FUNÇÃO

Acts as a transcriptional activator or repressor. Plays important roles in the early stage of organogenesis of the CNS. Activates the transcription of the serotonin transporter SERT in uncrossed ipsilateral retinal ganglion cells (iRGCs) to refine eye-specific projections in primary visual targets. Its transcriptional activity is repressed by MDFIC. Involved in the formation of the ipsilateral retinal projection at the optic chiasm midline. Drives the expression of EPHB1 on ipsilaterally project

LOCALIZAÇÃO

NucleusCytoplasm

VIAS BIOLÓGICAS (1)
Formation of the anterior neural plate
MECANISMO DE DOENÇA

Holoprosencephaly 5

A form of holoprosencephaly, a structural anomaly of the brain in which the developing forebrain fails to correctly separate into right and left hemispheres. It is a genetically and clinically heterogeneous disorder with a wide spectrum of severity, ranging from alobar holoprosencephaly with severe facial abnormalities, such as cyclopia and proboscis, to mild forms that include lobar or microform holoprosencephaly, without cerebral malformations and with mild craniofacial defects. HPE5 inheritance is autosomal dominant.

EXPRESSÃO TECIDUAL(Tecido-específico)
Cérebro - Hemisfério cerebelar
298.1 TPM
Cerebelo
248.3 TPM
Córtex cerebral
9.4 TPM
Brain Anterior cingulate cortex BA24
8.5 TPM
Brain Frontal Cortex BA9
7.4 TPM
OUTRAS DOENÇAS (6)
holoprosencephaly 5microform holoprosencephalyalobar holoprosencephalyobsolete midline interhemispheric variant of holoprosencephaly
HGNC:12873UniProt:O95409
FGF8Fibroblast growth factor 8Disease-causing germline mutation(s) inModerado
FUNÇÃO

Plays an important role in the regulation of embryonic development, cell proliferation, cell differentiation and cell migration. Required for normal brain, eye, ear and limb development during embryogenesis. Required for normal development of the gonadotropin-releasing hormone (GnRH) neuronal system (PubMed:16384934, PubMed:16597617, PubMed:8663044). Plays a role in neurite outgrowth in hippocampal cells (PubMed:21576111)

LOCALIZAÇÃO

Secreted

VIAS BIOLÓGICAS (1)
Formation of the posterior neural plate
MECANISMO DE DOENÇA

Hypogonadotropic hypogonadism 6 with or without anosmia

A disorder characterized by absent or incomplete sexual maturation by the age of 18 years, in conjunction with low levels of circulating gonadotropins and testosterone and no other abnormalities of the hypothalamic-pituitary axis. In some cases, it is associated with non-reproductive phenotypes, such as anosmia, cleft palate, and sensorineural hearing loss. Anosmia or hyposmia is related to the absence or hypoplasia of the olfactory bulbs and tracts. Hypogonadism is due to deficiency in gonadotropin-releasing hormone and probably results from a failure of embryonic migration of gonadotropin-releasing hormone-synthesizing neurons. In the presence of anosmia, idiopathic hypogonadotropic hypogonadism is referred to as Kallmann syndrome, whereas in the presence of a normal sense of smell, it has been termed normosmic idiopathic hypogonadotropic hypogonadism (nIHH).

EXPRESSÃO TECIDUAL(Baixa expressão)
Testículo
1.2 TPM
Córtex cerebral
0.6 TPM
Linfócitos
0.6 TPM
Brain Frontal Cortex BA9
0.6 TPM
Brain Anterior cingulate cortex BA24
0.5 TPM
OUTRAS DOENÇAS (8)
hypogonadotropic hypogonadism 6 with or without anosmiamicroform holoprosencephalyKallmann syndromehypogonadotropic hypogonadism
HGNC:3686UniProt:P55075
SIX3Homeobox protein SIX3Disease-causing germline mutation(s) inAltamente restrito
FUNÇÃO

Transcriptional regulator which can act as both a transcriptional repressor and activator by binding a ATTA homeodomain core recognition sequence on these target genes. During forebrain development represses WNT1 expression allowing zona limitans intrathalamica formation and thereby ensuring proper anterio-posterior patterning of the diencephalon and formation of the rostral diencephalon. Acts as a direct upstream activator of SHH expression in the rostral diencephalon ventral midline and that i

LOCALIZAÇÃO

Nucleus

MECANISMO DE DOENÇA

Holoprosencephaly 2

A form of holoprosencephaly, a structural anomaly of the brain in which the developing forebrain fails to correctly separate into right and left hemispheres. It is a genetically and clinically heterogeneous disorder with a wide spectrum of severity, ranging from alobar holoprosencephaly with severe facial abnormalities, such as cyclopia and proboscis, to mild forms that include lobar or microform holoprosencephaly, without cerebral malformations and with mild craniofacial defects. HPE2 inheritance is autosomal dominant.

EXPRESSÃO TECIDUAL(Tecido-específico)
Brain Nucleus accumbens basal ganglia
52.0 TPM
Pituitária
42.5 TPM
Brain Caudate basal ganglia
41.0 TPM
Brain Putamen basal ganglia
30.8 TPM
Hipotálamo
13.7 TPM
OUTRAS DOENÇAS (8)
holoprosencephaly 2schizencephalyacquired schizencephalyalobar holoprosencephaly
HGNC:10889UniProt:O95343
DLL1Delta-like protein 1Disease-causing germline mutation(s) inAltamente restrito
FUNÇÃO

Transmembrane ligand protein of NOTCH1, NOTCH2 and NOTCH3 receptors that binds the extracellular domain (ECD) of Notch receptor in a cis and trans fashion manner (PubMed:11006133). Following transinteraction, ligand cells produce mechanical force that depends of a clathrin-mediated endocytosis, requiring ligand ubiquitination, EPN1 interaction, and actin polymerisation; these events promote Notch receptor extracellular domain (NECD) transendocytosis and triggers Notch signaling through induction

LOCALIZAÇÃO

Apical cell membraneCell junction, adherens junctionMembrane raft

VIAS BIOLÓGICAS (10)
Differentiation of Keratinocytes in Interfollicular Epidermis in Mammalian SkinNOTCH2 Activation and Transmission of Signal to the NucleusActivated NOTCH1 Transmits Signal to the NucleusConstitutive Signaling by NOTCH1 PEST Domain MutantsSomitogenesis
MECANISMO DE DOENÇA

Neurodevelopmental disorder with non-specific brain abnormalities and with or without seizures

An autosomal dominant disorder characterized by developmental delay, intellectual disability, seizures, autism spectrum disorder, behavioral abnormalities, and variable non-specific brain malformations.

EXPRESSÃO TECIDUAL(Ubíquo)
Baço
97.4 TPM
Próstata
53.9 TPM
Skin Sun Exposed Lower leg
41.0 TPM
Vagina
40.4 TPM
Skin Not Sun Exposed Suprapubic
40.1 TPM
OUTRAS DOENÇAS (7)
neurodevelopmental disorder with nonspecific brain abnormalities and with or without seizuresmicroform holoprosencephalyobsolete midline interhemispheric variant of holoprosencephalylobar holoprosencephaly
HGNC:2908UniProt:O00548
CDONCell adhesion molecule-related/down-regulated by oncogenesDisease-causing germline mutation(s) inTolerante
FUNÇÃO

Component of a cell-surface receptor complex that mediates cell-cell interactions between muscle precursor cells. Promotes differentiation of myogenic cells (By similarity)

LOCALIZAÇÃO

Cell membrane

VIAS BIOLÓGICAS (3)
Activation of SMOLigand-receptor interactionsMyogenesis
MECANISMO DE DOENÇA

Holoprosencephaly 11

A form of holoprosencephaly, a structural anomaly of the brain in which the developing forebrain fails to correctly separate into right and left hemispheres. It is a genetically and clinically heterogeneous disorder with a wide spectrum of severity, ranging from alobar holoprosencephaly with severe facial abnormalities, such as cyclopia and proboscis, to mild forms that include lobar or microform holoprosencephaly, without cerebral malformations and with mild craniofacial defects. HPE11 inheritance is autosomal dominant.

OUTRAS DOENÇAS (7)
holoprosencephaly 11alobar holoprosencephalypituitary stalk interruption syndromelobar holoprosencephaly
HGNC:17104UniProt:Q4KMG0
NODALNodal homologDisease-causing germline mutation(s) inRestrito
FUNÇÃO

Essential for mesoderm formation and axial patterning during embryonic development

LOCALIZAÇÃO

Secreted

VIAS BIOLÓGICAS (2)
Signaling by NODALRegulation of signaling by NODAL
MECANISMO DE DOENÇA

Heterotaxy, visceral, 5, autosomal

An autosomal dominant form of visceral heterotaxy, a complex disorder due to disruption of the normal left-right asymmetry of the thoracoabdominal organs. Visceral heterotaxy or situs ambiguus results in randomization of the placement of visceral organs, including the heart, lungs, liver, spleen, and stomach. The organs are oriented randomly with respect to the left-right axis and with respect to one another. It can be associated with a variety of congenital defects including cardiac malformations. HTX5 clinical features include situs inversus viscerum or situs ambiguus, congenital heart defect, transposition of the great vessels ventricular septal defect, atrial septal defect, truncus communis, and dextrocardia.

EXPRESSÃO TECIDUAL(Baixa expressão)
Testículo
3.4 TPM
Cerebelo
2.8 TPM
Cervix Ectocervix
2.3 TPM
Cérebro - Hemisfério cerebelar
2.2 TPM
Skin Sun Exposed Lower leg
2.0 TPM
OUTRAS DOENÇAS (8)
heterotaxy, visceral, 5, autosomalmicroform holoprosencephalyvisceral heterotaxyalobar holoprosencephaly
HGNC:7865UniProt:Q96S42
TGIF1Homeobox protein TGIF1Disease-causing germline mutation(s) inAltamente restrito
FUNÇÃO

Binds to a retinoid X receptor (RXR) responsive element from the cellular retinol-binding protein II promoter (CRBPII-RXRE). Inhibits the 9-cis-retinoic acid-dependent RXR alpha transcription activation of the retinoic acid responsive element. Active transcriptional corepressor of SMAD2. Links the nodal signaling pathway to the bifurcation of the forebrain and the establishment of ventral midline structures. May participate in the transmission of nuclear signals during development and in the adu

LOCALIZAÇÃO

Nucleus

VIAS BIOLÓGICAS (2)
Downregulation of SMAD2/3:SMAD4 transcriptional activitySMAD2/SMAD3:SMAD4 heterotrimer regulates transcription
MECANISMO DE DOENÇA

Holoprosencephaly 4

A form of holoprosencephaly, a structural anomaly of the brain in which the developing forebrain fails to correctly separate into right and left hemispheres. It is a genetically and clinically heterogeneous disorder with a wide spectrum of severity, ranging from alobar holoprosencephaly with severe facial abnormalities, such as cyclopia and proboscis, to mild forms that include lobar or microform holoprosencephaly, without cerebral malformations and with mild craniofacial defects. HPE4 inheritance is autosomal dominant.

EXPRESSÃO TECIDUAL(Ubíquo)
Fibroblastos
29.3 TPM
Fallopian Tube
21.4 TPM
Próstata
18.7 TPM
Pulmão
18.4 TPM
Skin Not Sun Exposed Suprapubic
18.3 TPM
OUTRAS DOENÇAS (6)
holoprosencephaly 4microform holoprosencephalyobsolete septopreoptic holoprosencephalylobar holoprosencephaly
HGNC:11776UniProt:Q15583
GAS1Growth arrest-specific protein 1Disease-causing germline mutation(s) inModerado
FUNÇÃO

Specific growth arrest protein involved in growth suppression. Blocks entry to S phase. Prevents cycling of normal and transformed cells. Binds 20(S)-hydroxycholesterol (20(S)-OHC) (By similarity)

LOCALIZAÇÃO

Cell membrane

VIAS BIOLÓGICAS (2)
Activation of SMOLigand-receptor interactions
EXPRESSÃO TECIDUAL(Ubíquo)
Útero
191.2 TPM
Fallopian Tube
164.2 TPM
Adipose Visceral Omentum
112.1 TPM
Ovário
94.2 TPM
Fibroblastos
88.8 TPM
OUTRAS DOENÇAS (5)
lobar holoprosencephalyobsolete septopreoptic holoprosencephalyobsolete midline interhemispheric variant of holoprosencephalyalobar holoprosencephaly
HGNC:4165UniProt:P54826
FOXH1Forkhead box protein H1Disease-causing germline mutation(s) inTolerante
FUNÇÃO

Transcriptional activator. Recognizes and binds to the DNA sequence 5'-TGT[GT][GT]ATT-3'. Required for induction of the goosecoid (GSC) promoter by TGF-beta or activin signaling. Forms a transcriptionally active complex containing FOXH1/SMAD2/SMAD4 on a site on the GSC promoter called TARE (TGF-beta/activin response element)

LOCALIZAÇÃO

Nucleus

VIAS BIOLÓGICAS (4)
Germ layer formation at gastrulationFormation of axial mesodermSignaling by ActivinSignaling by NODAL
EXPRESSÃO TECIDUAL(Baixa expressão)
Testículo
1.6 TPM
Cólon transverso
1.1 TPM
Intestino delgado
0.8 TPM
Pituitária
0.7 TPM
Cerebelo
0.6 TPM
OUTRAS DOENÇAS (5)
alobar holoprosencephalyobsolete midline interhemispheric variant of holoprosencephalyobsolete septopreoptic holoprosencephalymicroform holoprosencephaly
HGNC:3814UniProt:O75593
STILSCL-interrupting locus proteinDisease-causing germline mutation(s) inTolerante
FUNÇÃO

Immediate-early gene. Plays an important role in embryonic development as well as in cellular growth and proliferation; its long-term silencing affects cell survival and cell cycle distribution as well as decreases CDK1 activity correlated with reduced phosphorylation of CDK1. Plays a role as a positive regulator of the sonic hedgehog pathway, acting downstream of PTCH1 (PubMed:16024801, PubMed:9372240). Plays an important role in the regulation of centriole duplication. Required for the onset o

LOCALIZAÇÃO

Cytoplasm, cytosolCytoplasm, cytoskeleton, microtubule organizing center, centrosome, centrioleCytoplasm, cell cortex

EXPRESSÃO TECIDUAL(Tecido-específico)
Linfócitos
21.9 TPM
Testículo
9.8 TPM
Fibroblastos
5.8 TPM
Esôfago - Mucosa
3.5 TPM
Intestino delgado
2.9 TPM
OUTRAS DOENÇAS (7)
microcephaly 7, primary, autosomal recessiveautosomal recessive primary microcephalyalobar holoprosencephalyprecursor T-cell acute lymphoblastic leukemia
HGNC:10879UniProt:Q15468
STAG2Cohesin subunit SA-2Disease-causing germline mutation(s) (loss of function) inAltamente restrito
FUNÇÃO

Component of cohesin complex, a complex required for the cohesion of sister chromatids after DNA replication. The cohesin complex apparently forms a large proteinaceous ring within which sister chromatids can be trapped. At anaphase, the complex is cleaved and dissociates from chromatin, allowing sister chromatids to segregate. The cohesin complex may also play a role in spindle pole assembly during mitosis

LOCALIZAÇÃO

NucleusChromosomeChromosome, centromere

VIAS BIOLÓGICAS (2)
Establishment of Sister Chromatid CohesionResolution of Sister Chromatid Cohesion
MECANISMO DE DOENÇA

Mullegama-Klein-Martinez syndrome

An X-linked neurodevelopmental disorder with variable features including intellectual deficiency, microcephaly, microtia, hearing loss, developmental delay, dysmorphic features, language delay, congenital heart defect, and clinodactyly of the 5th finger.

EXPRESSÃO TECIDUAL(Ubíquo)
Linfócitos
49.9 TPM
Ovário
38.0 TPM
Fibroblastos
36.7 TPM
Cervix Endocervix
36.4 TPM
Útero
35.4 TPM
OUTRAS DOENÇAS (4)
Mullegama-Klein-Martinez syndromeholoprosencephaly 13, X-linkedXq25 microduplication syndromealobar holoprosencephaly
HGNC:11355UniProt:Q8N3U4
SMC1AStructural maintenance of chromosomes protein 1ADisease-causing germline mutation(s) (loss of function) inAltamente restrito
FUNÇÃO

Involved in chromosome cohesion during cell cycle and in DNA repair. Central component of cohesin complex. The cohesin complex is required for the cohesion of sister chromatids after DNA replication. The cohesin complex apparently forms a large proteinaceous ring within which sister chromatids can be trapped. At anaphase, the complex is cleaved and dissociates from chromatin, allowing sister chromatids to segregate. The cohesin complex may also play a role in spindle pole assembly during mitosis

LOCALIZAÇÃO

NucleusChromosomeChromosome, centromere, kinetochore

VIAS BIOLÓGICAS (2)
Establishment of Sister Chromatid CohesionResolution of Sister Chromatid Cohesion
MECANISMO DE DOENÇA

Cornelia de Lange syndrome 2

A form of Cornelia de Lange syndrome, a clinically heterogeneous developmental disorder associated with malformations affecting multiple systems. Characterized by facial dysmorphisms, abnormal hands and feet, growth delay, cognitive retardation, hirsutism, gastroesophageal dysfunction and cardiac, ophthalmologic and genitourinary anomalies.

EXPRESSÃO TECIDUAL(Ubíquo)
Linfócitos
50.6 TPM
Cérebro - Hemisfério cerebelar
34.9 TPM
Útero
33.4 TPM
Cervix Endocervix
29.0 TPM
Artéria tibial
28.1 TPM
OUTRAS DOENÇAS (4)
developmental and epileptic encephalopathy, 85, with or without midline brain defectsCornelia de Lange syndrome 2Cornelia de Lange syndromeatypical Rett syndrome
HGNC:11111UniProt:Q14683
CRIPTOProtein CriptoDisease-causing germline mutation(s) inTolerante
FUNÇÃO

GPI-anchored cell membrane protein involved in Nodal signaling. Cell-associated CRIPTO acts as a Nodal coreceptor in cis. Shedding of CRIPTO by TMEM8A modulates Nodal signaling by allowing soluble CRIPTO to act as a Nodal coreceptor on other cells (PubMed:27881714). Could play a role in the determination of the epiblastic cells that subsequently give rise to the mesoderm (PubMed:11909953)

LOCALIZAÇÃO

Cell membraneSecreted

VIAS BIOLÓGICAS (3)
Signaling by NODALRegulation of signaling by NODALPOU5F1 (OCT4), SOX2, NANOG activate genes related to proliferation
OUTRAS DOENÇAS (5)
microform holoprosencephalyobsolete midline interhemispheric variant of holoprosencephalyalobar holoprosencephalylobar holoprosencephaly
HGNC:11701UniProt:P13385
DISP1Protein dispatched homolog 1Disease-causing germline mutation(s) inTolerante
FUNÇÃO

Functions in hedgehog (Hh) signaling. Regulates the release and extracellular accumulation of cholesterol-modified hedgehog proteins and is hence required for effective production of the Hh signal (By similarity). Synergizes with SCUBE2 to cause an increase in SHH secretion (PubMed:22902404)

LOCALIZAÇÃO

Membrane

MECANISMO DE DOENÇA

Holoprosencephaly 10

A form of holoprosencephaly, a structural anomaly of the brain in which the developing forebrain fails to correctly separate into right and left hemispheres. It is a genetically and clinically heterogeneous disorder with a wide spectrum of severity, ranging from alobar holoprosencephaly with severe facial abnormalities, such as cyclopia and proboscis, to mild forms that include lobar or microform holoprosencephaly, without cerebral malformations and with mild craniofacial defects. HPE10 inheritance pattern is autosomal recessive. Autosomal dominant inheritance with incomplete penetrance or oligogenic inheritance have been reported in some families.

EXPRESSÃO TECIDUAL(Ubíquo)
Pulmão
17.4 TPM
Nervo tibial
16.3 TPM
Cólon sigmoide
15.6 TPM
Testículo
13.9 TPM
Esôfago - Junção
11.0 TPM
OUTRAS DOENÇAS (6)
holoprosencephaly 10alobar holoprosencephalyobsolete midline interhemispheric variant of holoprosencephalylobar holoprosencephaly
HGNC:19711UniProt:Q96F81
SHHSonic hedgehog proteinDisease-causing germline mutation(s) inAltamente restrito
FUNÇÃO

The C-terminal part of the sonic hedgehog protein precursor displays an autoproteolysis and a cholesterol transferase activity (By similarity). Both activities result in the cleavage of the full-length protein into two parts (ShhN and ShhC) followed by the covalent attachment of a cholesterol moiety to the C-terminal of the newly generated ShhN (By similarity). Both activities occur in the endoplasmic reticulum (By similarity). Once cleaved, ShhC is degraded in the endoplasmic reticulum (By simi

LOCALIZAÇÃO

Endoplasmic reticulum membraneGolgi apparatus membraneSecretedCell membrane

VIAS BIOLÓGICAS (5)
Hedgehog 'on' stateActivation of SMOLigand-receptor interactionsRelease of Hh-Np from the secreting cellFormation of lateral plate mesoderm
MECANISMO DE DOENÇA

Microphthalmia/Coloboma 5

A disorder of eye formation, ranging from small size of a single eye to complete bilateral absence of ocular tissues. Ocular abnormalities like opacities of the cornea and lens, scaring of the retina and choroid, and other abnormalities may also be present. Ocular colobomas are a set of malformations resulting from abnormal morphogenesis of the optic cup and stalk, and the fusion of the fetal fissure (optic fissure).

EXPRESSÃO TECIDUAL(Tecido-específico)
Nervo tibial
21.7 TPM
Glândula adrenal
7.7 TPM
Fígado
7.4 TPM
Estômago
3.8 TPM
Rim - Medula
3.5 TPM
OUTRAS DOENÇAS (15)
microphthalmia, isolated, with coloboma 5holoprosencephaly 3solitary median maxillary central incisor syndrometibia, hypoplasia or aplasia of, with polydactyly
HGNC:10848UniProt:Q15465
PTCH1Protein patched homolog 1Disease-causing germline mutation(s) inAltamente restrito
FUNÇÃO

Acts as a receptor for sonic hedgehog (SHH), indian hedgehog (IHH) and desert hedgehog (DHH). Associates with the smoothened protein (SMO) to transduce the hedgehog's proteins signal. Seems to have a tumor suppressor function, as inactivation of this protein is probably a necessary, if not sufficient step for tumorigenesis

LOCALIZAÇÃO

Cell membrane

VIAS BIOLÓGICAS (4)
Hedgehog 'on' stateActivation of SMOLigand-receptor interactionsHedgehog 'off' state
MECANISMO DE DOENÇA

Basal cell nevus syndrome 1

A form of basal cell nevus syndrome, a disease characterized by nevoid basal cell carcinomas and developmental abnormalities such as rib and craniofacial alterations, polydactyly, syndactyly, and spina bifida. In addition, the patients suffer from a multitude of tumors like fibromas of the ovaries and heart, cysts of the skin, jaws and mesentery, as well as medulloblastomas and meningiomas. BCNS1 inheritance is autosomal dominant.

EXPRESSÃO TECIDUAL(Ubíquo)
Cérebro - Hemisfério cerebelar
35.1 TPM
Cerebelo
34.9 TPM
Nervo tibial
33.6 TPM
Testículo
17.2 TPM
Bladder
9.1 TPM
OUTRAS DOENÇAS (11)
basal cell carcinoma, susceptibility to, 1holoprosencephaly 7basal cell nevus syndrome 1obsolete septopreoptic holoprosencephaly
HGNC:9585UniProt:Q13635
GLI2Zinc finger protein GLI2Disease-causing germline mutation(s) inAltamente restrito
FUNÇÃO

Functions as a transcription regulator in the hedgehog (Hh) pathway (PubMed:18455992, PubMed:26565916). Functions as a transcriptional activator (PubMed:19878745, PubMed:24311597, PubMed:9557682). May also function as transcriptional repressor (By similarity). Requires STK36 for full transcriptional activator activity. Required for normal embryonic development (PubMed:15994174, PubMed:20685856) Involved in the smoothened (SHH) signaling pathway Involved in the smoothened (SHH) signaling pathway

LOCALIZAÇÃO

NucleusCytoplasmCell projection, cilium

VIAS BIOLÓGICAS (2)
Hedgehog 'off' stateHedgehog 'on' state
MECANISMO DE DOENÇA

Holoprosencephaly 9

A form of holoprosencephaly, a structural anomaly of the brain in which the developing forebrain fails to correctly separate into right and left hemispheres. It is a genetically and clinically heterogeneous disorder with a wide spectrum of severity, ranging from alobar holoprosencephaly with severe facial abnormalities, such as cyclopia and proboscis, to mild forms that include lobar or microform holoprosencephaly, without cerebral malformations and with mild craniofacial defects. HPE9 is characterized by defective anterior pituitary formation and pan-hypopituitarism, with or without overt forebrain cleavage abnormalities, and holoprosencephaly-like midfacial hypoplasia. HPE9 inheritance is autosomal dominant.

EXPRESSÃO TECIDUAL(Ubíquo)
Ovário
22.1 TPM
Útero
11.2 TPM
Cervix Endocervix
10.1 TPM
Cervix Ectocervix
9.0 TPM
Fibroblastos
7.9 TPM
OUTRAS DOENÇAS (8)
postaxial polydactyly-anterior pituitary anomalies-facial dysmorphism syndromeholoprosencephaly 9combined pituitary hormone deficiencies, genetic formobsolete midline interhemispheric variant of holoprosencephaly
HGNC:4318UniProt:P10070
FGFR1Fibroblast growth factor receptor 1Disease-causing germline mutation(s) inAltamente restrito
FUNÇÃO

Tyrosine-protein kinase that acts as a cell-surface receptor for fibroblast growth factors and plays an essential role in the regulation of embryonic development, cell proliferation, differentiation and migration. Required for normal mesoderm patterning and correct axial organization during embryonic development, normal skeletogenesis and normal development of the gonadotropin-releasing hormone (GnRH) neuronal system. Phosphorylates PLCG1, FRS2, GAB1 and SHB. Ligand binding leads to the activati

LOCALIZAÇÃO

Cell membraneNucleusCytoplasm, cytosolCytoplasmic vesicle

VIAS BIOLÓGICAS (2)
Epithelial-Mesenchymal Transition (EMT) during gastrulationFormation of paraxial mesoderm
MECANISMO DE DOENÇA

Pfeiffer syndrome

A syndrome characterized by the association of craniosynostosis, broad and deviated thumbs and big toes, and partial syndactyly of the fingers and toes. Three subtypes are known: mild autosomal dominant form (type 1); cloverleaf skull, elbow ankylosis, early death, sporadic (type 2); craniosynostosis, early demise, sporadic (type 3).

EXPRESSÃO TECIDUAL(Ubíquo)
Aorta
144.8 TPM
Ovário
142.9 TPM
Artéria tibial
134.1 TPM
Fallopian Tube
122.3 TPM
Cérebro - Hemisfério cerebelar
122.0 TPM
OUTRAS DOENÇAS (20)
Hartsfield-Bixler-Demyer syndromeencephalocraniocutaneous lipomatosisosteoglophonic dysplasiaPfeiffer syndrome
HGNC:3688UniProt:P11362

Variantes genéticas (ClinVar)

345 variantes patogênicas registradas no ClinVar.

🧬 ZIC2: NM_007129.5(ZIC2):c.106C>G (p.Gln36Glu) ()
🧬 ZIC2: GRCh38/hg38 13q31.3-34(chr13:89779269-114338054)x1 ()
🧬 ZIC2: NM_007129.5(ZIC2):c.1114C>T (p.Arg372Trp) ()
🧬 ZIC2: NM_007129.5(ZIC2):c.1487G>T (p.Gly496Val) ()
🧬 ZIC2: NM_007129.5(ZIC2):c.1226G>C (p.Arg409Pro) ()
Ver todas no ClinVar

Classificação de variantes (ClinVar)

Distribuição de 3 variantes classificadas pelo ClinVar.

3
Patogênica (100.0%)
VARIANTES MAIS SIGNIFICATIVAS
FGFR1: NM_023110.3(FGFR1):c.1977+1G>A [Pathogenic/Likely pathogenic]
FGF8: NM_033163.5(FGF8):c.356C>T (p.Thr119Met) [Likely pathogenic]
FGF8: NM_033163.5(FGF8):c.317C>A (p.Ala106Glu) [Likely pathogenic]

Vias biológicas (Reactome)

85 vias biológicas associadas aos genes desta condição.

Formation of the anterior neural plate PI3K Cascade PIP3 activates AKT signaling Signaling by activated point mutants of FGFR1 Signaling by activated point mutants of FGFR3 FGFR4 ligand binding and activation FGFR3b ligand binding and activation FGFR3c ligand binding and activation FGFR1c ligand binding and activation FGFR2c ligand binding and activation Activated point mutants of FGFR2 Constitutive Signaling by Aberrant PI3K in Cancer Phospholipase C-mediated cascade: FGFR1 Phospholipase C-mediated cascade; FGFR2 Phospholipase C-mediated cascade; FGFR3 Phospholipase C-mediated cascade; FGFR4 Downstream signaling of activated FGFR1 SHC-mediated cascade:FGFR1 PI-3K cascade:FGFR1 FRS-mediated FGFR1 signaling PI-3K cascade:FGFR2 SHC-mediated cascade:FGFR2 FRS-mediated FGFR2 signaling SHC-mediated cascade:FGFR3 FRS-mediated FGFR3 signaling PI-3K cascade:FGFR3 FRS-mediated FGFR4 signaling SHC-mediated cascade:FGFR4 PI-3K cascade:FGFR4 Negative regulation of FGFR1 signaling Negative regulation of FGFR2 signaling Transcription of NOTCH2NLB gene Activated NOTCH1 Transmits Signal to the Nucleus Constitutive Signaling by NOTCH1 PEST Domain Mutants Constitutive Signaling by NOTCH1 t(7;9)(NOTCH1:M1580_K2555) Translocation Mutant Constitutive Signaling by NOTCH1 HD Domain Mutants Constitutive Signaling by NOTCH1 HD+PEST Domain Mutants NOTCH2 Activation and Transmission of Signal to the Nucleus NOTCH3 Activation and Transmission of Signal to the Nucleus MECP2 regulates transcription of neuronal ligands Differentiation of Keratinocytes in Interfollicular Epidermis in Mammalian Skin Formation of paraxial mesoderm Somitogenesis Nephron development Myogenesis Ligand-receptor interactions Activation of SMO Signaling by NODAL Regulation of signaling by NODAL Downregulation of SMAD2/3:SMAD4 transcriptional activity SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription Signaling by Activin Germ layer formation at gastrulation Formation of axial mesoderm Phosphorylated Orc1 is ubiquitinated while still associated with chromatin Meiotic synapsis Separation of Sister Chromatids Establishment of Sister Chromatid Cohesion Cohesin Loading onto Chromatin Resolution of Sister Chromatid Cohesion SUMOylation of DNA damage response and repair proteins Estrogen-dependent gene expression POU5F1 (OCT4), SOX2, NANOG activate genes related to proliferation Class B/2 (Secretin family receptors) Hedgehog ligand biogenesis Hh mutants are degraded by ERAD Release of Hh-Np from the secreting cell Hedgehog 'on' state HHAT G278V doesn't palmitoylate Hh-Np Formation of lateral plate mesoderm Developmental Lineage of Multipotent Pancreatic Progenitor Cells Hedgehog 'off' state Degradation of GLI2 by the proteasome GLI proteins bind promoters of Hh responsive genes to promote transcription RUNX2 regulates chondrocyte maturation Signaling by FGFR1 amplification mutants FGFR1b ligand binding and activation FGFR1c and Klotho ligand binding and activation NCAM signaling for neurite out-growth Signal transduction by L1 Signaling by FGFR1 in disease RAF/MAP kinase cascade PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling Signaling by plasma membrane FGFR1 fusions Epithelial-Mesenchymal Transition (EMT) during gastrulation

Diagnóstico

Os sinais que médicos procuram e os exames que confirmam

Carregando...

Tratamento e manejo

Remédios, cuidados de apoio e o que precisa acompanhar

Carregando informações de tratamento...

Onde tratar no SUS

Hospitais de referência no Brasil e o protocolo oficial do SUS (PCDT)

🇧🇷 Atendimento SUS — Holoprosencefalia semilobar

🗺️

Selecione um estado ou use sua localização para ver resultados.

Dados de DATASUS/CNES, SBGM, ABNeuro e Ministério da Saúde. Sempre confirme a disponibilidade diretamente com o estabelecimento.

Pesquisa ativa

Ensaios clínicos abertos e novidades científicas recentes

Pesquisa e ensaios clínicos

Nenhum ensaio clínico registrado para esta condição.

🧪 Está conduzindo uma pesquisa?
Divulgue para pacientes e familiares que acompanham esta doença.
Divulgar pesquisa →

Publicações mais relevantes

Timeline de publicações
31 papers (10 anos)
#1

Congenital Syngnathia With Holoprosencephaly: A Case Report of a Fatal Presentation in a Resource-Limited Setting.

Clinical case reports2025 Dec

Congenital syngnathia, the rare fusion of the maxilla and mandible, poses significant feeding and respiratory challenges. Its management is complicated by rarity and potential syndromic associations. We present a 1-week-old female neonate who presented with left jaw deviation, respiratory distress (SpO2 69%, tachypnea), and fever. Examination revealed near-complete inability to open the mouth except for a small right paramedical gap. A CT scan confirmed left maxilla-mandibular bony fusion (Laster type 2b, Dawson type 2b), mandibular hypoplasia, semilobar holoprosencephaly, corpus callosal dysgenesis, a dorsal cyst, and microcephaly. Concurrent neonatal sepsis was diagnosed. Management included antibiotics, NG tube feeding, and oxygen support. Surgical intervention was deferred due to critical instability. Despite supportive care, the infant's condition deteriorated, resulting in fatal respiratory failure. This case underscores the lethal potential of congenital syngnathia when compounded by severe CNS malformations. The CNS anomalies induced hypoventilation and aspiration, making surgery nonviable and leading to sepsis and respiratory failure. The absence of antenatal care prevented early detection and tertiary delivery planning. Prompt neuroimaging is crucial, and prognosis is heavily dictated by CNS comorbidities, necessitating consideration of palliative prioritization in resource-limited settings.

#2

Sublingual Administration of Desmopressin Oral Disintegrating Tablet in a Neonate With Central Diabetes Insipidus.

Cureus2025 Jul

Precise titration of desmopressin (1-deamino-8-D-arginine vasopressin; DDAVP) is essential for managing neonatal central diabetes insipidus (CDI). Although oral administration is increasingly considered an alternative to the traditional intranasal route, the differences between DDAVP formulations and administration methods are often unclear in clinical practice. This complicates efforts to establish effective sublingual treatment protocols using oral disintegrating tablets (ODTs) in neonates. Here, we present the case of a Japanese neonate with CDI, semilobar holoprosencephaly, and a cleft lip and palate. The patient exhibited hypotonic polyuria, hypernatremia, elevated serum osmolality, and low plasma arginine vasopressin (AVP) levels within the first week of life. At 30 days of age, we dissolved a 60-µg DDAVP ODT in 5 mL of water and administered it sublingually. The initial dose of 3 µg/kg/day was titrated to 2 µg/kg/day based on the patient's clinical response. Close monitoring enabled fine adjustment of dosing. The patient achieved a stable fluid balance and did not exhibit signs of hyponatremia, seizures, or other adverse events. This case supports the potential utility of sublingual DDAVP ODTs in neonates and underscores the necessity of establishing standardized preparation and dosing protocols, which will require further clinical experience.

#3

Centriolar protein PIBF1 is required for craniofacial and forebrain development.

Developmental biology2025 Nov

Primary cilia are microtubule based extensions on the surface of most cells that play a crucial role in cellular signaling during development, tissue homeostasis, and organ function. Defective cilia result in a wide variety of clinical manifestations affecting multiple organ systems, collectively termed ciliopathies. Ciliopathies are rare, exhibit tremendous genetic diversity and an overlap of clinical features, making diagnosis and treatment challenging. Identifying and characterizing novel ciliary variants is critical to gain an improved understanding of ciliopathic pathologies. To address this need, we performed a forward genetic screen using N-ethyl-N-nitrosourea (ENU) mutagenesis and subsequent complementation analysis. We found a novel variant in Pibf1, a gene essential for ciliogenesis and previously linked to the ciliopathy, Joubert syndrome. Pibf1m1Bei/Null embryos exhibited a collection of craniofacial anomalies associated with ciliopathies including midline defects, maxillary hyperplasia, micrognathia, and high arched palate. Interestingly, Pibf1m1Bei/Null embryos also presented with semilobar holoprosencephaly, a phenotype not typically associated with ciliopathies. Molecular analysis revealed aberrant Shh expression and GLI3 processing concomitant with an expansion of Fgf8 and Lhx6 expression across structures in the face, brain, and oral cavity. In summary, these data suggest a role for PIBF1 and cilia in establishing proper SHH/FGF8 signaling axes across the embryo and suggest that holoprosencephaly is a part of the ciliopathic phenotypic spectrum associated with Joubert syndrome.

#4

Prenatal diagnosis of Hartsfield syndrome with a novel genetic variant.

Prenatal diagnosis2023 Dec

A G2P0, 24-year-old woman presented at 17 weeks 3 days gestation for a fetal anatomy scan. Ultrasound identified bilateral upper and lower extremity ectrodactyly, semilobar holoprosencephaly, midface hypoplasia, and cleft lip and palate. Amniocentesis for a chromosome microarray demonstrated no significant copy number changes. Whole exome sequencing was subsequently completed, which revealed a de novo, likely pathogenic variant in FGFR1, c.2044G>A (D682N), consistent with FGFR1-related Hartsfield syndrome. This case highlights the first presumed molecularly confirmed prenatal diagnosis of Hartsfield syndrome and identifies a new pathogenic variant.

#5

Semilobar Holoprosencephaly Caused by a Novel and De Novo ZIC2 Pathogenic Variant.

Balkan journal of medical genetics : BJMG2023 May

Holoprosencephaly (HPE) is the most common embryonic forebrain developmental anomaly. It involves incomplete or absent division of the prosencephalon into two distinct cerebral hemispheres during the early stages of organogenesis. HPE is etiologically heterogeneous, and its clinical presentation is very variable. We report a case of a 7 month old female infant, diagnosed with non-syndromic semilobar holoprosencephaly, caused by a novel, de novo pathogenic variant in ZIC2 - one of the most commonly mutated genes in non-syndromic HPE coding for the ZIC2 transcription factor. The patient presented with microcephaly, mild facial dysmorphic features, central hypotonia and spasticity on all four extremities. Ultrasound imaging demonstrated the absence of septum pellucidum, semilobar fusion of the hemispheres and mega cisterna magna and brain MRI with confirmed the diagnosis of HPE. Early diagnosis and management are important for the prevention and treatment of complications associated with this condition.

Publicações recentes

Ver todas no PubMed

📚 EuropePMC48 artigos no totalmostrando 31

2025

Congenital Syngnathia With Holoprosencephaly: A Case Report of a Fatal Presentation in a Resource-Limited Setting.

Clinical case reports
2025

Sublingual Administration of Desmopressin Oral Disintegrating Tablet in a Neonate With Central Diabetes Insipidus.

Cureus
2025

Centriolar protein PIBF1 is required for craniofacial and forebrain development.

Developmental biology
2023

Prenatal diagnosis of Hartsfield syndrome with a novel genetic variant.

Prenatal diagnosis
2023

Semilobar Holoprosencephaly Caused by a Novel and De Novo ZIC2 Pathogenic Variant.

Balkan journal of medical genetics : BJMG
2023

The role of routine first-trimester ultrasound screening for central nervous system abnormalities: a longitudinal single-center study using an unselected cohort with 3-year experience.

BMC pregnancy and childbirth
2023

Holoprosencephaly in Patau Syndrome.

Revista paulista de pediatria : orgao oficial da Sociedade de Pediatria de Sao Paulo
2023

Antenatal and Postnatal Diagnosis of Semilobar Holoprosencephaly: Two Case Reports.

Global pediatric health
2023

INDIAMAN-20 (INstant DIAgnosis of 20 Major ANomalies) protocol: application of IOTA diagnostic strategy to fetal anomalies.

Ultrasound in obstetrics &amp; gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology
2022

Intracerebral retina-like pigmented tissue in a stillborn fetus with holoprosencephaly.

Clinical neuropathology
2021

Carbamazepine-Responsive Chorea in a Toddler with Semilobar Holoprosencephaly: Case Report.

Journal of pediatric neurosciences
2021

CEP135 associated primary microcephaly-A rare presentation in early second trimester.

European journal of medical genetics
2020

Semilobar Holoprosencephaly: Capacious Anomaly in the Cephalad.

Cureus
2019

Holoprosencephaly, orofacial cleft, and frontonaso-orbital encephaloceles: Genetic evaluation of a possible new syndrome.

American journal of medical genetics. Part A
2019

Antenatal sonographic diagnosis of semilobar holoprosencephaly with associated cleft lip and palate.

BJR case reports
2019

A CCR4-NOT Transcription Complex, Subunit 1, CNOT1, Variant Associated with Holoprosencephaly.

American journal of human genetics
2020

Nasal fistula, epidermal cyst and hypernatremia in a girl presenting holoprosencephaly due to a rare ZIC2 point mutation.

European journal of medical genetics
2018

Digynic triploidy in a fetus presenting with semilobar holoprosencephaly.

Taiwanese journal of obstetrics &amp; gynecology
2019

SEC31A mutation affects ER homeostasis, causing a neurological syndrome.

Journal of medical genetics
2018

Semilobar holoprosencephaly with cebocephaly associated with maternal early onset preeclampsia: a case report.

Journal of medical case reports
2017

Semi Lobar Holoprosencephaly with Vertebral Segmentation Defects.

Iranian journal of child neurology
2017

Semilobarholoprosencephaly - A Dreading Congenital Anomaly.

Journal of clinical and diagnostic research : JCDR
2017

Pancreas and gallbladder agenesis in a newborn with semilobar holoprosencephaly, a case report.

BMC medical genetics
2016

Semilobar holoprosencephaly in a 12-month-old baby boy born to a primigravida patient with type 1 diabetes mellitus: a case report.

Journal of medical case reports
2016

Holoprosencephaly and Pure Red Cell Aplasia in a Feline Leukaemia Virus-Positive Kitten.

Journal of comparative pathology
2015

Two patients with small chromosome 22q11.21 alterations and central nervous system abnormalities.

Molecular cytogenetics
2016

Central Diabetes Insipidus in Infancy With or Without Hypothalamic Adipsic Hypernatremia Syndrome: Early Identification and Outcome.

The Journal of clinical endocrinology and metabolism
2015

Semilobar Holoprosencephaly with Congenital Oropharyngeal Stenosis in a Term Neonate.

AJP reports
2015

A NEW OBSERVATION OF 13q DELETION SYNDROME: SEVERE UNDESCRIBED FEATURES.

Genetic counseling (Geneva, Switzerland)
2015

Variant course of bilateral anterior cerebral artery in semilobar holoprosencephaly.

Surgical and radiologic anatomy : SRA
2016

Semilobar Holoprosencephaly Associated with Multiple Malformations in a Foal.

Anatomia, histologia, embryologia
Ver todos os 48 no EuropePMC

Associações

Organizações que acompanham esta doença — pra ter apoio e orientação

Ainda não temos associações cadastradas para Holoprosencefalia semilobar.

É de uma associação que acompanha esta doença? Fale com a gente →

Comunidades

Grupos ativos de quem convive com esta doença aqui no Raras

Ainda não existe comunidade no Raras para Holoprosencefalia semilobar

Pacientes, familiares e cuidadores se organizam em comunidades pra compartilhar experiências, fazer perguntas e se apoiar. Você pode ser o primeiro.

Tire suas dúvidas

Perguntas, dicas e experiências compartilhadas aqui na página

Participe da discussão

Faça login para postar dúvidas, compartilhar experiências e interagir com especialistas.

Fazer login

Doenças relacionadas

Doenças com sintomas parecidos — ajudam quem ainda está buscando diagnóstico

Ordenadas pelo número de sintomas em comum.

Referências e fontes

Bases de dados externas citadas neste artigo

Publicações científicas

Artigos indexados no PubMed ligados a esta doença no grafo RarasNet — título, periódico e PMID direto da fonte, sem intermediação de IA.

  1. Congenital Syngnathia With Holoprosencephaly: A Case Report of a Fatal Presentation in a Resource-Limited Setting.
    Clinical case reports· 2025· PMID 41383531mais citado
  2. Sublingual Administration of Desmopressin Oral Disintegrating Tablet in a Neonate With Central Diabetes Insipidus.
    Cureus· 2025· PMID 40809652mais citado
  3. Centriolar protein PIBF1 is required for craniofacial and forebrain development.
    Developmental biology· 2025· PMID 40774570mais citado
  4. Prenatal diagnosis of Hartsfield syndrome with a novel genetic variant.
    Prenatal diagnosis· 2023· PMID 38013637mais citado
  5. Semilobar Holoprosencephaly Caused by a Novel and De Novo ZIC2 Pathogenic Variant.
    Balkan journal of medical genetics : BJMG· 2023· PMID 37265970mais citado

Bases de dados e fontes oficiais

Identificadores e referências canônicas usadas para montar este verbete.

  1. ORPHA:220386(Orphanet)
  2. MONDO:0700419(MONDO)
  3. Variantes catalogadas(ClinVar)
  4. Busca completa no PubMed(PubMed)
  5. Q13538944(Wikidata)

Dados compilados pelo RarasNet a partir de fontes abertas (Orphanet, OMIM, MONDO, PubMed/EuropePMC, ClinicalTrials.gov, DATASUS, PCDT/MS). Este conteúdo é informativo e não substitui avaliação médica.

Conteúdo mantido por Agente Raras · Médicos e pesquisadores podem colaborar

Compêndio · Raras BR

Holoprosencefalia semilobar

ORPHA:220386 · MONDO:0700419
Prevalência
1-9 / 100 000
Herança
Multigenic/multifactorial, Not applicable
CID-10
Q04.2 · Holoprosencefalia
CID-11
Início
Infancy, Neonatal
Prevalência
0.0 (Europe)
MedGen
UMLS
C0751617
EuropePMC
Wikidata
Papers 10a
DiscussaoAtiva

Nenhuma novidade ainda. O agente esta monitorando.

0membros
0novidades